Skip to content
Fencer Intel
high 7.6

CVE-2014-5406 json

Hospira LifeCare PCA Infusion System

published 2015-07-06 11 y ago modified 2026-06-17 4 mo ago also EUVD-2014-5294

cvss
7.6
version 2.0, CNA
cisa kev
Not listed
not in CISA's catalog
epss
1.2%
EPSS 1.2% chance of exploitation in 30 days, percentile 68%
public exploits
0
none known

Summary

The Hospira LifeCare PCA Infusion System before 7.0 does not validate network traffic associated with sending a (1) drug library, (2) software update, or (3) configuration change, which allows remote attackers to modify settings or medication data via packets on the (a) TELNET, (b) HTTP, (c) HTTPS, or (d) UPNP port. NOTE: this issue might overlap CVE-2015-3459.

Patch / fix

  • Hospira LifeCare PCA Infusion System 7.0

Vendor advisories

What the vendors themselves say about their products: affected, fixed or not affected, and what to do.

cisa ICSA-15-125-01B updated cvss 7.6

Hospira LifeCare PCA Infusion System Vulnerabilities

  • Hospira LifeCare PCA Infusion System <=5.0
    affected: mitigation “For additional information about Hospira’s upcoming release, contact Hospira’s technical support at 1-800-241-4002.”

From CISA ICS and IT advisories (CSAF, https://github.com/cisagov/CSAF), a U.S. Government work; changed: reduced to products, statuses and remediations. CISA notification · csaf

Exploit prediction

1.22% chance of exploitation in the next 30 days, higher than 68% of all scored CVEs (FIRST EPSS, 2026-11-09).

CVSS scores

assigned by version score vector
CNA 2.0 7.6 AV:N/AC:H/Au:N/C:C/I:C/A:C
NVD 2.0 9.3 AV:N/AC:M/Au:N/C:C/I:C/A:C

Affected products

  • Hospira LifeCare PCA Infusion System

Classification

Weakness
  • CWE-345 Insufficient Verification of Data Authenticity

References

Sources

Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.